Evolutionary risk assessment of European SARS-related bat coronaviruses
Evolutionary risk assessment of European SARS-related bat coronaviruses
批准号:
458682210
负责人:
Professor Dr. Jan Felix Drexler
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2021
资助国家:
德国
项目状态:
已结题
起止时间:
2020-12-31 至 2022-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Alike the highly pathogenic SARS-CoV and MERS-CoV, the evolutionary origins of SARS-CoV-2 lie in bats. Both SARS-CoV and SARS-CoV-2 likely originated in China in bats belonging to the genus Rhinolophus. However, a large diversity of SARS-related CoV strains exist in European rhinolophid bats. Exhaustive genomic and molecular analyses of one European SARS-related CoV by us during the last decade revealed differences in pathogenicity, including cellular entry and interferon antagonism. For all other European bat SARS-related CoVs, only small genomic fragments have been characterized. Divergent bat coronaviruses from China were found to infect primate cells via the ACE2 receptor and a large viral diversity, including multiple recombination events, was described from a single bat cave in China. Together with the independent emergence of SARS-CoV and SARS-CoV-2, this highlights the zoonotic potential of highly diverse bat SARS-related CoVs. Whether European SARS-related bat CoVs pose risks for human health remains unclear. In WP1 (Reservoir studies), we will acquire complete genome data using in solution capture-enriched high throughput sequencing (HTS) to determine up to 100 divergent SARS-related CoV genomes. In WP2 (Evolutionary analyses), we will investigate the origins and evolutionary patterns of rhinolophid SARS-related CoVs to identify macro-evolutionary patterns and SARS-related CoV strains particularly prone to hosts switching. In WP3 (In silico modeling of spike-receptor interactions) we will sequence ACE2 orthologues from different Rhinolophus bat species and other mammalian hosts and predict the capacity of spike glycoproteins of European SARS-related bat CoVs to interact with those ACE2 orthologues. The results of EURO-SARS have direct implications for risk mitigation strategies of potential future SARS-related CoV outbreaks, inform pathogenesis studies and aid adjustment of diagnostic tools, therapeutics and vaccine candidates.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ecology and species barriers of emerging bat hepatitis B viruses
-
批准号:226347449
-
项目类别:Priority Programmes
-
资助金额:$0.0万
-
财政年份:2013
-
负责人:Professor Dr. Jan Felix Drexler
-
依托单位:
Comparative investigation of the genealogy of hepatitis B virus
-
批准号:537500489
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:--
-
负责人:Professor Dr. Jan Felix Drexler
-
依托单位:
国内基金
海外基金
登录
查看更多内容
The Heterogenous Impact of Monetary Policy on Firms' Risk and Fundamentals
-
批准号:--
-
项目类别:外国学者研究基金项目
-
资助金额:--
-
批准年份:2024
-
负责人:潘军
-
依托单位:
面向人工智能生成内容的风险识别与治理策略研究
-
批准号:72304290
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:向安玲
-
依托单位:
基于影像代谢重塑可视化的延胡索酸水合酶缺陷型肾癌危险性分层模型的研究
-
批准号:82371912
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:吴广宇
-
依托单位:
基于移动健康技术干预动脉粥样硬化性心血管疾病高危人群的随机对照现场试验:The ASCVD Risk Intervention Trial
-
批准号:81973152
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2019
-
负责人:胡东生
-
依托单位:
基于时间序列间分位相依性(quantile dependence)的风险值(Value-at-Risk)预测模型研究
-
批准号:71903144
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2019
-
负责人:张申
-
依托单位:
RISK通路在胃泌素介导的心脏缺血再灌注损伤保护中的作用研究
-
批准号:81800239
-
项目类别:青年科学基金项目
-
资助金额:21.0万元
-
批准年份:2018
-
负责人:符金娟
-
依托单位:
异氟烷基于TLR4/RISK/NF-κB调控糖尿病缺血性脑卒中后NLRP3炎症小体形成的机制研究
-
批准号:81771232
-
项目类别:面上项目
-
资助金额:54.0万元
-
批准年份:2017
-
负责人:张鸿飞
-
依托单位:
Notch1与RISK/SAFE/HIF-1α信号通路整合在I-postC保护中的作用及其机制
-
批准号:81260024
-
项目类别:地区科学基金项目
-
资助金额:50.0万元
-
批准年份:2012
-
负责人:刘季春
-
依托单位:
基于VaR的水资源短缺风险综合模型体系与应用
-
批准号:51279006
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2012
-
负责人:王红瑞
-
依托单位:
黄淮海平原典型区域土壤盐渍化演变机制与发生风险防控对策研究
-
批准号:41171178
-
项目类别:面上项目
-
资助金额:65.0万元
-
批准年份:2011
-
负责人:刘广明
-
依托单位: